The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes - Author's commentary

被引：0
作者：
Tucker, GT [1 ]
机构：
[1] Univ Sheffield, Royal Hallamshire Hosp, Div Clin Sci S,Acda Unit Clin Pharmacol, Pharmacokinet & Pharmacogenet Grp, Sheffield S10 2JF, S Yorkshire, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 58卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S748 / S749
页数：2
相关论文
共 6 条
[1]   FLUOXETINE AND NORFLUOXETINE ARE POTENT INHIBITORS OF P450IID6 - THE SOURCE OF THE SPARTEINE DEBRISOQUINE OXIDATION POLYMORPHISM [J].
BROSEN, K ;
SKJELBO, E .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 32 (01) :136-137
[2]   THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON CYTOCHROME-P4502D6 (CYP2D6) ACTIVITY IN HUMAN LIVER-MICROSOMES [J].
CREWE, HK ;
LENNARD, MS ;
TUCKER, GT ;
WOODS, FR ;
HADDOCK, RE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (03) :262-265
[3]   A REVIEW OF THE METABOLISM AND PHARMACOKINETICS OF PAROXETINE IN MAN [J].
KAYE, CM ;
HADDOCK, RE ;
LANGLEY, PF ;
MELLOWS, G ;
TASKER, TCG ;
ZUSSMAN, BD ;
GREB, WH .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 80 :60-75
[4]   THE RELATIONSHIP BETWEEN PAROXETINE AND THE SPARTEINE OXIDATION POLYMORPHISM [J].
SINDRUP, SH ;
BROSEN, K ;
GRAM, LF ;
HALLAS, J ;
SKJELBO, E ;
ALLEN, A ;
ALLEN, GD ;
COOPER, SM ;
MELLOWS, G ;
TASKER, TCG ;
ZUSSMAN, BD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (03) :278-287
[5]  
TUCKER GT, 1992, INT J CLIN PHARM TH, V30, P550
[6]   FLUOXETINE-INDUCED TRICYCLIC TOXICITY - EXTENT AND DURATION [J].
WESTERMEYER, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) :388-392
1